Alvaro
Hernandez Vicente
University of Oxford
Oxford, Reino UnidoPublikationen in Zusammenarbeit mit Forschern von University of Oxford (2)
2023
-
Value of increased soluble suppressor tumorigenicity biomarker 2 (sST2) on admission as an indicator of severity in patients with COVID-19
Medicina Clinica, Vol. 161, Núm. 5, pp. 185-191
2021
-
Colchicine in recently hospitalized patients with COVID-19: A randomized controlled trial (COL-COVID)
International Journal of General Medicine, Vol. 14, pp. 5517-5526